Outlook Therapeutics (OTLK) Return on Assets (2016 - 2026)
Outlook Therapeutics (OTLK) posted quarterly Return on Assets of 0.03% for Q1 2026, down 2.0% year-over-year from 0.03% in Q1 2025, and up 48.82% quarter-over-quarter from 0.05% in Q4 2025.
Outlook Therapeutics (OTLK) Return on Assets (2016 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Return on Assets for 11 consecutive years, with 0.03% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets fell 2.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (down 2.0% YoY), while the FY2025 annual figure was 0.03%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.03% in Q1 2026 per OTLK's latest filing, from 0.05% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q1 2022 and bottomed at 0.05% in Q4 2025.
- Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2023.
- Annual changes were most pronounced in 2024 — Return on Assets declined 3 bps — and 2025, when it grew 3 bps.
- Outlook Therapeutics' Return on Assets stood at 0.02% in 2022, then decreased by 24 bps to 0.02% in 2023, then sank by 99 bps to 0.04% in 2024, then plunged by 37 bps to 0.05% in 2025, then soared by 49 bps to 0.03% in 2026.
- Business Quant data shows OTLK's Return on Assets at 0.03% in Q1 2026, 0.05% in Q4 2025, and 0.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - | 0.00% |
| 10 | Outlook Therapeutics | 94.22 Mn | 82.97 Mn | -8,265.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.05% |
| Jun 30, 2025 | -0.04% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.01% |